{"entity":{"type":"insider","cik":"0001666485","url":"/insider/0001666485","json_url":"/insider/0001666485.json","name":"BIOS Memory SPV II, LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":3,"first":"2022-11-16","last":"2022-11-29","span_basis":"filed_date"},"name_variants":[{"name":"BIOS Memory SPV II, LP","source":"filing","n_filings":3,"first_seen":"2022-11-16","last_seen":"2022-11-29"}],"transactions":[{"id":6771086,"accession":"0001104659-22-122622","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-122622","line_url":"/filing/0001104659-22-122622","is_derivative":false,"issuer_cik":"0001455365","issuer_name":"COGNITION THERAPEUTICS INC","issuer_ticker":"CGTX","issuer_name_source":null,"issuer_url":"/issuer/0001455365","owner_cik":null,"owner_name":"BIOS Memory SPV II, LP; Cavu Advisors, LLC; BIOS Fund II NT, LP; BIOS Fund III, LP; Cavu Management, LP; BIOS Equity Partners III, LP; BIOS Fund III QP, LP; BIOS Fund III NT, LP; Kreis Leslie W.","owner_display_name":"BIOS Memory SPV II, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16064.0,"shares_display":"16,064","price_per_share":2.6497,"price_display":"2.65","price_state":"stated","total_value":42564.7808,"total_display":"42,564.78","total_whole":"42,565","shares_owned_after":2021906.0,"shares_owned_after_display":"2,021,906","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-28","filed_date":"2022-11-29","scope":"insider","n_lines":3},{"id":6269279,"accession":"0001104659-22-119719","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-119719","line_url":"/filing/0001104659-22-119719","is_derivative":false,"issuer_cik":"0001455365","issuer_name":"COGNITION THERAPEUTICS INC","issuer_ticker":"CGTX","issuer_name_source":null,"issuer_url":"/issuer/0001455365","owner_cik":null,"owner_name":"BIOS Equity Partners III, LP; BIOS Fund III QP, LP; BIOS Fund II NT, LP; BIOS Fund III, LP; Kreis Leslie W.; Cavu Management, LP; BIOS Memory SPV II, LP; Cavu Advisors, LLC; BIOS Fund III NT, LP","owner_display_name":"BIOS Equity Partners III, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":71000.0,"shares_display":"71,000","price_per_share":1.4,"price_display":"1.40","price_state":"stated","total_value":99400.0,"total_display":"99,400.00","total_whole":"99,400","shares_owned_after":2009686.0,"shares_owned_after_display":"2,009,686","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-16","filed_date":"2022-11-17","scope":"insider","n_lines":3},{"id":6269270,"accession":"0001104659-22-119339","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-119339","line_url":"/filing/0001104659-22-119339","is_derivative":false,"issuer_cik":"0001455365","issuer_name":"COGNITION THERAPEUTICS INC","issuer_ticker":"CGTX","issuer_name_source":null,"issuer_url":"/issuer/0001455365","owner_cik":null,"owner_name":"Kreis Leslie W.; Cavu Advisors, LLC; BIOS Equity Partners III, LP; BIOS Fund III QP, LP; BIOS Fund II NT, LP; BIOS Fund III, LP; BIOS Memory SPV II, LP; BIOS Fund III NT, LP; Cavu Management, LP","owner_display_name":"Kreis Leslie W.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500000.0,"shares_display":"1,500,000","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":1800000.0,"total_display":"1,800,000.00","total_whole":"1,800,000","shares_owned_after":1955677.0,"shares_owned_after_display":"1,955,677","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-15","filed_date":"2022-11-16","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001455365","name":"COGNITION THERAPEUTICS INC","url":"/issuer/0001455365","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2022-11-16","last_seen":"2022-11-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001666485","retrieved_at":"2026-08-26T12:50:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}